This review summarises most currently used indices to assess and monitor patients with
systemic lupus erythematosus (SLE) in clinical trials, long-term observational studies, and …

Lymphocytic infiltration of different exocrine and non-exocrine epithelia is the pathological
hallmark of primary Sjögren's syndrome, whereas involvement of salivary and lachrymal …

Objective To compare the efficacy and safety of intravenous (IV) abatacept, a selective T cell
costimulation modulator, versus placebo for the treatment of active class III or IV lupus …

Importance Patients with cutaneous lupus erythematosus (CLE) who develop systemic lupus
erythematosus (SLE) may have few and mild systemic symptoms. Objective To characterize …

Background In a prospective observational study, we investigated whether patients with
active systemic lupus erythematosus (SLE) had higher indices of endothelial damage and …

The objective of this study is to evaluate the association of clinical features and prognosis
with age at disease onset in patients with systemic lupus erythematosus (SLE) in a large …

Background Alternative therapeutic options are needed for patients with systemic lupus
erythematosus (SLE) not adequately controlled with or intolerant to traditional treatments …

Objective Rising anti-double-stranded (ds) DNA titers have been shown by some, but not all,
studies to be predictive of disease flares in systemic lupus erythematosus (SLE). We …

The incidence of clinical fractures and the associated factors were assessed in patients with
systemic lupus erythematosus (SLE) versus matched controls. We found an increased …

Objective. To determine whether mucocutaneous manifestations are associated with major
organ involvement in a UK national cohort of juvenile-onset SLE (JSLE) patients. Methods …